SCHEMBL7974480

SCHEMBL7974480

CCOc1ccc(-c2nc(=O)c3c(ncn3Cc3ccccc3)[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 1/20 0.50
PARN O95453 1/20 0.47
CNOT7 Q9UIV1 1/20 0.47
P2RX7 Q99572 2/20 0.43
ADORA2B P29275 1/20 0.43
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 2/20 0.41
TP53 P04637 2/20 0.41
RAB9A P51151 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987774 0.92 CNOT7 (0.46) GUSBPARNCNOT7ADORA2BSMN1; SMN2
SCHEMBL7985228 0.90 CXCR2 (0.50) GUSBPARNCNOT7P2RX7ALDH1A1
SCHEMBL7974409 0.89 PARN (0.45) PARNCNOT7P2RX7ALDH1A1MAPT
SCHEMBL7975271 0.88 CNOT7 (0.56) PARNCNOT7ADORA2BALDH1A1SMN1; SMN2
SCHEMBL7985707 0.86 CYP11B2 (0.47) GUSBPARNCNOT7P2RX7ALDH1A1
SCHEMBL7975135 0.85 CNOT7 (0.52) PARNCNOT7ADORA2BALDH1A1MAPT
SCHEMBL7984461 0.85 CNOT7 (0.52) GUSBPARNCNOT7ADORA2BALDH1A1
SCHEMBL7974461 0.85 CNOT7 (0.49) PARNCNOT7ADORA2BALDH1A1SMN1; SMN2
SCHEMBL7988562 0.84 CNOT7 (0.54) GUSBPARNCNOT7ADORA2BALDH1A1
SCHEMBL7974508 0.84 CNOT7 (0.51) PARNCNOT7ADORA2BALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed